Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding

Eur Heart J. 2023 Apr 17;44(15):1287-1290. doi: 10.1093/eurheartj/ehad212.
No abstract available

MeSH terms

  • Coronary Restenosis*
  • Hemorrhage / etiology
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors / adverse effects
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors